Sexual dimorphism of the craniofacial region in a South Indian population

Share this Article

Singapore Med J 2013; 54(8): 458-462; http://dx.doi.org/10.11622/smedj.2013154
Sexual dimorphism of the craniofacial region in a South Indian population

Nidugala H, Bhargavi C, Avadhani R, Bhaskar B
Correspondence: Dr Bhagya Bhaskar, bagyabs@gmail.com

ABSTRACT
INTRODUCTION To the best of our knowledge, the sexually dimorphic characteristics of the craniofacial region among the South Indian population are not available in the current literature. We aimed to determine these characteristics using discriminant function analysis.
METHODS A total of 80 recent skulls (40 male, 40 female) from the Department of Anatomy, Yenepoya Medical College, Yenepoya University, Karnataka, India, were analysed. Ten craniofacial parameters were measured and subjected to univariate and multivariate statistical analyses using the Statistical Package for the Social Sciences version 13.0.
RESULTS Statistical analyses revealed that the differences in the bizygomatic, orbital and biorbital breadths of males and females were significant (p < 0.05). Direct method gave an accuracy of 68.8% for sex determination. In stepwise analysis, bizygomatic breadth and upper facial height were selected, giving a 65.0% accuracy for sex prediction.
CONCLUSION Craniofacial parameters are sexually dimorphic. The present study established several features of craniofacial morphometry that can be used for sex determination among the South Indian population. The findings of the present study serve as a foundation for future studies that aim to compare craniofacial parameters among various ethnic groups in South India.

Keywords: craniofacial region, discriminant function analysis, metric parameters, sexual dimorphism, South Indian population 
Singapore Med J 2013; 54(8): 458-462; http://dx.doi.org/10.11622/smedj.2013154

REFERENCES

1. Rogers TL. Determination of sex of human remains through cranial morphology. J Forensic Sci 2005; 50:493-500.
http://dx.doi.org/10.1520/JFS2003385
 
2. Naccarato S, Petersen S, John GL. Skull features as clues to age, sex, race and lifestyle. J Forensic Ident 2008; 58:172-81.
 
3. Bilge Y, Kedici PS, Alakoç, YD, Ülküer KU, ?lkyaz YY. The identification of a dismembered human body: a multidisciplinary approach. Forensic Sci Int 2003; 137: 141-6.
http://dx.doi.org/10.1016/S0379-0738(03)00334-7
 
4. Saini V, Srivastava R, Rai RK, et al. An Osteometric Study of Northern Indian Populations for Sexual Dimorphism in Craniofacial region. J Forensic Sci 2011; 56:700-5.
http://dx.doi.org/10.1111/j.1556-4029.2011.01707.x
 
5. Franklin D, O'Higgins P, Oxnard CE, Dadour I. Discriminant function sexing of the mandible of indigenous South Africans. Forensic Sci Int 2008; 179:84.
http://dx.doi.org/10.1016/j.forsciint.2008.03.014
 
6. Gapert R, Black S, Last J. Sex determination from the foramen magnum: discriminant function analysis in an eighteenth and nineteenth century British sample. Int J Legal Med 2009; 123:25-33.
http://dx.doi.org/10.1007/s00414-008-0256-0
 
7. Kranioti EF, Iscan MY, Michalodimitrakis M. Craniometric analysis of modern Cretan population. Forensic Sci Int 2008; 180:110.
http://dx.doi.org/10.1016/j.forsciint.2008.06.018
 
8. Vodanovic M, Dumancic J, Demo Z, Mihelic D. [Determination of sex by discriminant function analysis of mandibles from two Croatian archeological sites.] Acta Stomatol Croat 2006; 40:263-77. Croatian.
 
9. Celbis O, Iscan MY, Soysal Z, Cagdir S. Sexual diagnosis of the glabellar region. Legal Med (Tokyo) 2001; 3:162-70.
http://dx.doi.org/10.1016/S1344-6223(01)00025-6
 
10. Kemkes A, Gobel T. Metric assessment of the ''mastoid triangle'' for sex determination: a validation study. J Forensic Sci 2006; 51:985-9.
http://dx.doi.org/10.1111/j.1556-4029.2006.00232.x
 
11. Suazo GIC, Zavando MDA, Smith RL. Sex determination using mastoid process measurements in Brazilian skulls. Int J Morphol 2008; 26:941-4.
 
12. Wescott DJ, Moore-Jansen PH. Metric variation in the human occipital bone: forensic anthropological applications. J Forensic Sci 2001; 46:1159-63.
 
13. Gulekon IN, Turgut HB. The external occipital protuberance: can it be used as a criterion in the determination of sex? J Forensic Sci 2003; 48:513-6.
 
14. Naikmasur VG, Shrivastava R, Mutalik S. Determination of sex in South Indians and immigrant Tibetans from cephalometric analysis and discriminant functions. Forensic Sci Int 2010; 197:122.e1-6.
 
15. Oladipo GS, Akande PA, Osogba IG, Yorkum KL. Anthropometric studies of inner canthal distance, outer canthal distance and canthal index of adult Ibibios. Asian J of Med Sci 2011; 3:14-6.
 
16. Steyn M , Iscan MY. Sexual dimorphism in the crania and mandibles of South African whites. Forensic Sci Int 1998; 98: 9-16.
http://dx.doi.org/10.1016/S0379-0738(98)00120-0
 
17. Dayal MR, Spocter MA, Bidmos MA. An assessment of sex using the skull of black South Africans by discriminant function analysis. Homo 2008; 59:209-21.
http://dx.doi.org/10.1016/j.jchb.2007.01.001
 
18. Krishan K. Anthropometry in Forensic Medicine and Forensic Science-'Forensic Anthropometry'. Internet J Forensic Sci 2007; 2(1).
 
19. Farkas LG , Posnick J C, Hreezko TM. Anthropometric growth study of the head. Cleft Palate Craniofac J 1992; 29:303-8.
http://dx.doi.org/10.1597/1545-1569(1992)029<0303:AGSOTH>2.3.CO;2
 
20. Franklin D, Freedman L, Milne N, Oxnard CE. A geometric morphometric study of sexual dimorphism in the crania of indigenous southern Africans. S. Afr J Sci 2006; 102:229-38.
 
21. Franklin D, Freedman L, Milne N. Sexual dimorphism and discriminant function sexing in indigenous South Africa crania. Homo 2005; 55:213-28.
http://dx.doi.org/10.1016/j.jchb.2004.08.001
 
22. Malhotra KC. Morphological composition of the people of India. J Hum Evol 1978; 7:45-53.
http://dx.doi.org/10.1016/S0047-2484(78)80035-9

Helicobacter hepaticus infection in primary hepatocellular carcinoma tissue

Share this Article

Singapore Med J 2013; 54(8): 451-457; http://dx.doi.org/10.11622/smedj.2013153
Helicobacter hepaticus infection in primary hepatocellular carcinoma tissue

Yang J, Ji S, Zhang Y, Wang J
Correspondence: Dr Jiangbin Wang, sciencel122@126.com

ABSTRACT
INTRODUCTION Helicobacter (H.) hepaticus infection causes chronic active hepatitis and induces hepatocellular tumours in A/JCr mice, but evidence of this in humans is scarce. This study aimed to demonstrate the correlation between H. hepaticus and human primary hepatocellular carcinoma (HCC).
METHODS The sera of 50 patients with primary HCC were tested for the presence of anti-H. pylori and anti-H. hepaticus immunoglobulin G (IgG) antibodies. The liver tissues of patients who tested positive for serum antibody were analysed for H. hepaticus-specific 16S rRNA, H. hepaticus cdtB, H. pylori cagA, H. pylori vacA and H. pylori ureC genes using polymerase chain reaction.
RESULTS After the anti-H. pylori antibodies in the serum samples were absorbed by H. pylori antigen, the anti-H. hepaticus IgG serum antibody detection rate was 50.0% in patients with primary HCC. This was significantly higher (p < 0.001) than the detection rate in the benign liver tumour (7.7%) and normal liver tissue (6.3%) groups. Of the 25 primary HCC samples that tested positive for anti-H. hepaticus IgG serum antibody, the H. hepaticus-specific 16S rRNA gene was detected in nine (36.0%) samples. Sequencing showed that the polymerase chain reaction-amplified product exhibited 95.5%–100% homology to the H. hepaticus-specific 16S rRNA gene. Among these nine primary HCC tissue samples, the H. hepaticus cdtB gene was detected in four (44.4%) samples, while no such expression was observed in the benign liver tumour or normal liver tissue groups.
CONCLUSION The present study identified the presence of H. hepaticus infection in patients with primary HCC using serological and molecular biological detection, suggesting that H. hepaticus infection may be involved in the progression of HCC.

Keywords: Helicobacter hepaticus, Helicobacter pylori, primary hepatocellular carcinoma
Singapore Med J 2013; 54(8): 451-457; http://dx.doi.org/10.11622/smedj.2013153

REFERENCES

1. El-Serag HB. Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 2002; 36 (5 Suppl 1):S74-83.
http://dx.doi.org/10.1053/jhep.2002.36807
 
2. Nissen NN, Martin P. Hepatocellular carcinoma: the high-risk patient. J Clin Gastroenterol 2002; 35 (5 Suppl 1):S79-85.
http://dx.doi.org/10.1097/00004836-200211002-00003
 
3. Smela ME, Currier SS, Bailey EA, Essigmann JM. The chemistry and biology of aflatoxin B(1): from mutational spectrometry to carcinogenesis. Carcinogenesis 2001; 22:535-45.
http://dx.doi.org/10.1093/carcin/22.4.535
 
4. Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med 2000; 248:171-83.
http://dx.doi.org/10.1046/j.1365-2796.2000.00742.x
 
5. Silini E, Bottelli R, Asti M, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study. Gastroenterology 1996; 111:199-205.
http://dx.doi.org/10.1053/gast.1996.v111.pm8698200
 
6. Wiese M, Berr F, Lafrenz M, Porst H, Oesen U. Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in Germany: a 20-year multicenter study. Hepatology 2000; 32:91-6.
http://dx.doi.org/10.1053/jhep.2000.8169
 
7. Barrett S, Goh J, Coughlan B, et al. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut 2001; 49:423-30.
http://dx.doi.org/10.1136/gut.49.3.423
 
8. Vandenplas Y. Helicobacter pylori infection. World J Gastroenterol 2000; 6:20-31.
 
9. Sakai T, Ogura Y, Narita J, et al. Simultaneous early adenocarcinoma and mucosaassociated lymphoid tissue (MALT) lymphoma of the stomach associated with Helicobacter pylori infection. Gastric Cancer 2003; 6:191-6.
http://dx.doi.org/10.1007/s10120-003-0241-8
 
10. Vergara M, Calvet X, Roqué M. Helicobacter pylori is a risk factor for peptic ulcer disease in cirrhotic patients. A meta-analysis. Eur J Gastroenterol Hepatol 2002; 14:717-22.
http://dx.doi.org/10.1097/00042737-200207000-00002
 
11. Ward JM, Fox JG, Anver MR, et al. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 1994; 86:1222-7.
http://dx.doi.org/10.1093/jnci/86.16.1222
 
12. Nilsson HO, J Taneera, M Castedal, et al. Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis. J Clin Microbiol 2000; 38:1072-6.
 
13. Vorobjova T, I Nilsson, S Terjajev, et al. Serum antibodies to enterohepatic Helicobacter spp. in patients with chronic liver diseases and in a population with high prevalence of H. pylori infection. Dig Liver Dis 2006; 38:171-6.
http://dx.doi.org/10.1016/j.dld.2005.12.008
 
14. Nilsson I, Kornilovs'ka I, Lindgren S, Ljungh A, Wadström T. Increased prevalence of seropositivity for non-gastric Helicobacter species in patients with autoimmune liver disease. J Med Microbiol 2003; 52:949-53.
http://dx.doi.org/10.1099/jmm.0.05344-0
 
15. Huang Y, Fan XG, Wang ZM, et al. Identification of Helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Pathol 2004; 57:1273-7.
http://dx.doi.org/10.1136/jcp.2004.018556
 
16. Shimoyama T, Takahashi R, Abe D, et al. Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases. J Gastroenterol Hepatol 2010; 25 Suppl 1:S86-9.
http://dx.doi.org/10.1111/j.1440-1746.2010.06224.x
 
17. Ananieva O, Nilsson I, Vorobjova T, Uibo R, Wadström T. Immune responses to biletolerant Helicobacter species in patients with chronic liver diseases, a randomized population group, and healthy blood donors. Clin Diagn Lab Immunol 2002; 9:1160-4.
 
18. Nilsson I, Lindgren S, Eriksson S, Wadström T. Serum antibodies to Helicobacter hepaticus and Helicobacter pylori in patients with chronic liver disease. Gut 2000; 46:410-4.
http://dx.doi.org/10.1136/gut.46.3.410
 
19. Ihrig M, Schrenzel MD, Fox JG. Differential susceptibility to hepatic inflammation and proliferation in AXB recombinant inbred mice chronically infected with Helicobacter hepaticus. Am J Pathol 1999; 155:571-82.
http://dx.doi.org/10.1016/S0002-9440(10)65152-8
 
20. Rogers AB, SR Boutin, MT Whary, et al. Progression of chronic hepatitis and preneoplasia in Helicobacter hepaticus-infected A/JCr mice. Toxicol Pathol 2004; 32:668-77.
http://dx.doi.org/10.1080/01926230490524247
 
21. Avenaud P, Marais A, Monteiro L, et al. Detection of Helicobacter species in the liver of patients with and without primary liver carcinoma. Cancer 2000; 89:1431-9.
http://dx.doi.org/10.1002/1097-0142(20001001)89:7<1431::AID-CNCR4>3.0.CO;2-5
 
22. Ponzetto A, Pellicano R, Leone N, et al. Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker? Med Hypotheses 2000; 54:275-7.
http://dx.doi.org/10.1054/mehy.1999.0987
 
23. Nilsson HO, Mulchandani R, Tranberg KG, Stenram U, Wadström T. Helicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma. Gastroenterology 2001; 120:323-4.
http://dx.doi.org/10.1053/gast.2001.21382
 
24. Fan XG, Peng XN, Huang Y, et al. Helicobacter species ribosomal DNA recovered from the liver tissue of chinese patients with primary hepatocellular carcinoma. Clin Infect Dis 2002; 35:1555-7.
http://dx.doi.org/10.1086/344770
 
25. Coppola N, De Stefano G, Marrocco C, et al. Absence of Helicobacter spp. in the liver of patients with primary or metastatic liver cancer. Hepatology 2002; 36:1300-1.
http://dx.doi.org/10.1053/jhep.2002.36367
 
26. Verhoef C, Pot RG, de Man RA, et al. Detection of identical Helicobacter DNA in the stomach and in the non-cirrhotic liver of patients with hepatocellular carcinoma. Eur J Gastroenterol Hepatol 2003; 15:1171-4.
http://dx.doi.org/10.1097/00042737-200311000-00004
 
27. Pellicano R, Mazzaferro V, Grigioni WF, et al. Helicobacter species sequences in liver samples from patients with and without hepatocellular carcinoma. World J Gastroenterol 2004; 10:598-601.
 
28. Ito K, M Nakamura, G Toda, et al. Potential role of Helicobacter pylori in hepatocarcinogenesis. Int J Mol Med 2004; 13:221-7.
 
29. Rocha M, Avenaud P, Ménard A, Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 2005; 54:396-401.
http://dx.doi.org/10.1136/gut.2004.042168
 
30. Fox JG, Li X, Yan L, et al. Chronic proliferative hepatitis in A/JCr mice associated with persistent Helicobacter hepaticus infection: a model of Helicobacter-induced carcinogenesis. Infect Immun 1996; 64:1548-58.
 
31. Murakami K, Takahashi R, Ono M, et al. Serodiagnosis of Helicobacter hepaticus infection in patients with liver and gastrointestinal diseases: western blot analysis and ELISA using a highly specific monoclonal antibody for H. hepaticus antigen. J Gastroenterol 2011; 46:1120-6.
http://dx.doi.org/10.1007/s00535-011-0414-x

Proximal femoral nail antirotation and third-generation Gamma nail: which is a better device for the treatment of intertrochanteric fractures?

Share this Article

Singapore Med J 2013; 54(8): 446-450; http://dx.doi.org/10.11622/smedj.2013152
Proximal femoral nail antirotation and third-generation Gamma nail: which is a better device for the treatment of intertrochanteric fractures?

Yang YH, Wang YR, Jiang SD, Jiang LS
Correspondence: Prof Sheng-Dan Jiang,  jiangsd@126.com

ABSTRACT
INTRODUCTION Proximal femoral nail antirotation (PFNA) and third-generation Gamma nail (Gamma 3) are widely used in the treatment of intertrochanteric fractures. However, it remains unclear which device achieves better clinical and radiographic outcomes when treating intertrochanteric fractures.
METHODS This study comprised 239 patients with intertrochanteric fractures treated with either PFNA or Gamma 3 for a minimum of 12 months. During surgery, the operative time, image intensifier time and amount of blood loss were recorded. Following surgery, we assessed reduction quality and implant position. At the final follow-up, postoperative complications, including femoral shaft fracture, cutout, reoperation, pneumonia, urinary tract infection, cerebral infarction, cardiac infarction and decubital ulcer, were recorded. In addition, walking ability was assessed using the Parker-Palmer mobility score.
RESULTS No difference was found in the operative time, image intensifier time and amount of blood loss between patients treated with PFNA and those treated with Gamma 3. The reduction quality of fractures treated with Gamma 3 was better than those treated with PFNA. However, there were no significant differences in implant position, walking ability and postoperative complications between the two groups. Although Gamma 3 resulted in better reduction quality, it did not provide any advantages in walking ability and postoperative complications when compared with PFNA.
CONCLUSION Therefore, we conclude that both PFNA and Gamma 3 are safe and reliable devices for the treatment of intertrochanteric fractures.

Keywords: intertrochanteric fractures, intramedullary fixation
Singapore Med J 2013; 54(8): 446-450; http://dx.doi.org/10.11622/smedj.2013152

REFERENCES

1. Wolfgang GL, Bryant MH, O'Neill JP. Treatment of intertrochanteric fracture of the femur using sliding screw plate fixation. Clin Orthop Relat Res 1982; 163:148-58.
 
2. Bannister GC, Gibson AG, Ackroyd CE, Newman JH. The fixation and prognosis of trochanteric fractures. A randomized prospective controlled trial. Clin Orthop Relat Res 1990; 254:242-6.
 
3. Simpson AH, Varty K, Dodd CA. Sliding hip screws: modes of failure. Injury 1989; 20:227-31.
http://dx.doi.org/10.1016/0020-1383(89)90120-4
 
4. Haentjens P, Lamraski G. Endoprosthetic replacement of unstable, comminuted intertrochanteric fracture of the femur in the elderly, osteoporotic patient: a review. Disabil Rehabil 2005; 27:1167-80.
http://dx.doi.org/10.1080/09638280500055966
 
5. Stappaerts KH, Deldycke J, Broos PL, et al. Treatment of unstable peritrochanteric fractures in elderly patients with a compression hip screw or with the Vandeputte (VDP) endoprosthesis: a prospective randomized study. J Orthop Trauma 1995; 9:292-7.
http://dx.doi.org/10.1097/00005131-199509040-00004
 
6. Kim SY, Kim YG, Hwang JK. Cementless calcar-replacement hemiarthroplasty compared with intramedullary fixation of unstable intertrochanteric fractures. A prospective, randomized study. J Bone Joint Surg Am 2005; 87:2186-92.
http://dx.doi.org/10.2106/JBJS.D.02768
 
7. Lenich A, Mayr E, Rüter A, Möckl Ch, Füchtmeier B. First results with the trochanter fixation nail (TFN): a report on 120 cases. Arch Orthop Trauma Surg 2006; 126:706-12.
http://dx.doi.org/10.1007/s00402-006-0117-6
 
8. Cleveland M, Bosworth DM, Thompson FR, Wilson HJ Jr, Ishizuka T. A ten-year analysis of intertrochanteric fractures of the femur. J Bone Joint Surg Am 1959; 41-A:1399-408.
 
9. Baumgaertner MR, Curtin SL, Lindskog DM, Keggi JM. The value of the tipapex distance in predicting failure of fixation of peritrochanteric fractures of the hip. J Bone Joint Surg Am 1995; 77:1058-64.
 
10. Parker MJ, Palmer CR. A new mobility score for predicting mortality after hip fracture. J Bone Joint Surg Br 1993; 75:797-8.
 
11. Yaozeng X, Dechun G, Huilin Y, Guangming Z, Xianbin W. Comparative study of trochanteric fracture treated with the proximal femoral nail antirotation and the third generation of gamma nail. Injury 2010; 41:1234-8.
http://dx.doi.org/10.1016/j.injury.2010.03.005
 
12. Rubio-Avila J, Madden K, Simunovic N,Bhandari M. Tip to apex distance in femoral intertrochanteric fractures: a systematic review. J Orthop Sci 2013; 18:592-8.
http://dx.doi.org/10.1007/s00776-013-0402-5
 
13. Andruszkow H, Frink M, Frömke C, et al. Tip apex distance, hip screw placement, and neck shaft angle as potential risk factors for cut-out failure of hipscrews after surgical treatment of intertrochanteric fractures. Int Orthop 2012; 36:2347-54.
http://dx.doi.org/10.1007/s00264-012-1636-0
 
14. Geller JA, Saifi C, Morrison TA, Macaulay W. Tip-apex distance of intramedullary devices as a predictor of cut-out failure in the treatment of peritrochanteric elderly hip fractures. Int Orthop 2010; 34:719-22.
http://dx.doi.org/10.1007/s00264-009-0837-7
 
15. Hsueh KK, Fang CK, Chen CM, et al. Risk factors in cutout of sliding hip screw in intertrochanteric fractures: an evaluation of 937 patients. Int Orthop 2012; 34:1273-6.
http://dx.doi.org/10.1007/s00264-009-0866-2
 
16. Leung KS, Procter P, Robioneck B, Behrens K. Geometric mismatch of the Gamma nail to the Chinese femur. Clin Orthop Relat Res 1996; (323):42-8.
http://dx.doi.org/10.1097/00003086-199602000-00006
 
17. Koval KJ, Sala DA, Kummer FJ, Zuckerman JD. Postoperative weightbearing after a fracture of the femoral neck or an intertrochanteric fracture. J Bone Joint Surg Am 1998; 80:352-6.
 
18. Koval KJ, Skovron ML, Aharonoff GB, Meadows SE, Zuckerman JD. Ambulatory ability after hip fracture. A prospective study in geriatric patients. Clin Orthop Relat Res 1995; (310):150-9.
 
19. van der Sluijs JA, Walenkamp GH. How predictable is rehabilitation after hip fracture? A prospective study of 134 patients. Acta Orthop Scand 1991; 62:567-72.
http://dx.doi.org/10.3109/17453679108994498

Intramedullary splinting of femoral shaft fractures in children with flexible nails: early results

Share this Article

Singapore Med J2013; 54(8): 441-445; http://dx.doi.org/10.11622/smedj.2013151
Intramedullary splinting of femoral shaft fractures in children with flexible nails: early results

Kaliya Perumal AK, Balasubramanian K
Correspondence: Dr Arun Kumar Kaliya Perumal, dr.arunkumar.orth@gmail.com

ABSTRACT
INTRODUCTION Indications for flexible intramedullary nailing, as well as advancements in this technique, have evolved considerably with time and individual experience. We implemented and studied a simplified version of the technique. Functional outcome, osseous union and related issues are discussed.
METHODS A total of 15 patients aged 5–15 years with diaphyseal femur fracture were selected for the study. The patients’ fractures were stabilised with flexible intramedullary nails through lateral entry alone. After a minimum follow-up period of six months, the outcomes were analysed.
RESULTS The mean patient age was 8.7 years, and patients were followed up for a mean duration of 12 months. Radiological union was achieved within a mean duration of 7.5 weeks. The outcomes were excellent in most of the cases.
CONCLUSION Adequate fixation was achieved through the use of flexible nails as intramedullary splints. The results were comparable to that of the original technique. Further study is obligatory.

Keywords: elastic stable intramedullary nailing, flexible intramedullary nailing, paediatric femur fracture
Singapore Med J2013; 54(8): 441-445; http://dx.doi.org/10.11622/smedj.2013151

REFERENCES

1. Khazzam M, Tassone C, Liu XC, et al. Use of flexible intramedullary nail fixation in treating femur fractures in children. Am J Orthop (Belle Mead NJ) 2009; 38:E49-55.
 
2. Metaizeau JP. Stable elastic intramedullary nailing for fractures of the femur in children. J Bone Joint Surg Br 2004; 86:954-7.
http://dx.doi.org/10.1302/0301-620X.86B7.15620
 
3. Barry M, Paterson JM. Flexible intramedullary nails for fractures in children. J Bone Joint Surg Br 2004; 86:947-53.
http://dx.doi.org/10.1302/0301-620X.86B7.15273
 
4. Flynn JM, Skaggs DL, Sponseller PD, et al. The operative management of pediatric fractures of the lower extremity. J Bone Joint Surg Am 2002; 84:2288-300.
 
5. Flynn JM, Schwend RM. Management of pediatric femoral shaft fractures. J Am Acad Orthop Surg 2004; 12:347-59.
 
6. Ligier JN, Metaizeau JP, Prévot J, Lascombes P. Elastic stable intramedullary nailing of femoral shaft fractures in children. J Bone Joint Surg Br 1988; 70:74-7.
 
7. Singh R, Sharma SC, Magu NK, Singla A. Titanium elastic nailing in pediatric femoral diaphyseal fractures. Indian J Orthop 2006; 40:29-34.
http://dx.doi.org/10.4103/0019-5413.34071
 
8. Saikia K, Bhuyan S, Bhattacharya T, Saikia S. Titanium elastic nailing in femoral diaphyseal fractures of children in 6-16 years of age. Indian J Orthop 2007; 41:381-5.
http://dx.doi.org/10.4103/0019-5413.33876
 
9. El-Adl G, Mostafa MF, Khalil MA, Enan A. Titanium elastic nail fixation for paediatric femoral and tibial fractures. Acta Orthop Belg 2009; 75:512-20.
 
10. Heybeli M, Muratli HH, Celebi L, Gülçek S, Biçimo?lu A. [The results of intramedullary fixation with titanium elastic nails in children with femoral fractures]. Acta Orthop Traumatol Turc 2004; 38:178-87. Turkish.
 
11. Mortier D, De Ridder K. Flexible intramedullary nailing in the treatment of diaphyseal fractures of the femur in preschool children. Acta Orthop Belg 2008; 74:190-4.
 
12. Flynn JM, Hresko T, Reynolds RA, et al. Titanium elastic nails for pediatric femur fractures: a multicenter study of early results with analysis of complications. J Pediatr Orthop 2001; 21:4-8.
http://dx.doi.org/10.1097/01241398-200101000-00003

Effect of using population-specific body mass index cutoff points in the risk assessment of pregnant Asian women for venous thromboembolism

Share this Article

Singapore Med J 2013; 54(8): 437-440; http://dx.doi.org/10.11622/smedj.2013150
Effect of using population-specific body mass index cutoff points in the risk assessment of pregnant Asian women for venous thromboembolism

Randhawa NK, Tan EK, Sabnis MA
Correspondence: Dr Nau’shil Kaur Randhawa, naushil_randhawa@yahoo.com.sg

ABSTRACT
INTRODUCTION Current international Royal College of Obstetricians and Gynaecologists (RCOG) guidelines list maternal obesity (body mass index [BMI] ≥ 30.0 kg/m2) as a risk factor for venous thromboembolism (VTE). Although the World Health Organization (WHO) has recommended lower BMI cutoff points for Asians when risk stratifying for diseases associated with obesity, this has not been extended to maternal obesity. In the present study, we compared the difference in using Asian-specific BMI cutoff points as opposed to those in international guidelines in determining the population at risk for VTE, as defined by RCOG guidelines.
METHODS All spontaneous deliveries (n = 94) and Caesarean sections (n = 41) over a three-week period, and instrumental deliveries (n = 15) over a two-month period, were reviewed and risk stratified based on Asian-specific, as well as international, BMI cut-off points.
RESULTS For the group that underwent spontaneous vaginal delivery, the percentage of patients at risk for VTE nearly doubled (from 8.5% to 16.0%) with the revised risk stratification, while that of patients who had instrumental delivery had more than a two-fold increase (250%). In the initial risk stratification of the post-Caesarean patients, none were at high risk of VTE. However, when the lower cut-off points of 27.5 kg/m2 and 23.0 kg/mwere used, one and three patients were respectively identified to be at high risk.
CONCLUSION Further research and consideration regarding the adjustment of international risk stratification guidelines to accommodate population-specific differences are required so that at-risk patients are not missed.

Keywords: ethnicity, pregnancy, puerperium, risk assessment, thromboembolism
Singapore Med J 2013; 54(8): 437-440; http://dx.doi.org/10.11622/smedj.2013150

REFERENCES

1. Lewis G, ed. The Confidential Enquiry into Maternal and Child Health (CEMACH). Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer - 2003-2005. The Seventh Report on Confidential Enquiries into Maternal Deaths in the United Kingdom. London: CEMACH, 2007.
 
2. Heit JA, Kobbervig CE, James AH, et al. Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year populationbased study. Ann Intern Med 2005; 143:697-706.
http://dx.doi.org/10.7326/0003-4819-143-10-200511150-00006
 
3. Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 2008; 6:632-7.
http://dx.doi.org/10.1111/j.1538-7836.2008.02921.x
 
4. Jacobsen AF, Skjeldestad FE, Sandset PM. Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study. J Thromb Haemost 2008; 6:905-12.
http://dx.doi.org/10.1111/j.1538-7836.2008.02961.x
 
5. James AH. Prevention and management of venous thromboembolism in pregnancy. Am J Med 2007; 120 (10 suppl 2):S26-34.
http://dx.doi.org/10.1016/j.amjmed.2007.08.011
 
6. Lindqvist P, Dahlback B, Marsal K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol 1999; 94:595-9.
http://dx.doi.org/10.1016/S0029-7844(99)00308-7
 
7. Bauersachs RM, Dudenhausen J, Faridi A, et al. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women. Thromb Haemost 2007; 98:1237-45.
 
8. World Health Organisation. Obesity and overweight: Fact sheet No 311, 2006 [online]. Available at: www.who.int/mediacentre/factsheets/fs311/. Accessed May 15, 2012.
 
9. Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. N Eng J Med 2008; 359:2025-33.
http://dx.doi.org/10.1056/NEJMra0707993
 
10. Royal College of Obstetricians and Gynaecologists (RCOG). Green-topGuideline No 37a: Reducing the risk of thrombosis and embolism during pregnancy and the puerperium. London: Royal College of Obstetricians and Gynaecologists (RCOG), 2009.
 
11. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363:157-63.
http://dx.doi.org/10.1016/S0140-6736(03)15268-3
 
12. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998; 22:1164-71.
http://dx.doi.org/10.1038/sj.ijo.0800741
 
13. Gallagher D, Visser, M, Sepulveda D, et al. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol 1996; 143:228-39.
http://dx.doi.org/10.1093/oxfordjournals.aje.a008733
 
14. Gurrici S, Hartriyanti Y, Hautvast JG, Deurenberg P. Relationship between body fat and body mass index: differences between Indonesians and Dutch Caucasians. Eur J Clin Nutr 1998; 52:779-83.
http://dx.doi.org/10.1038/sj.ejcn.1600637
 
15. He M, Tan KC, Li ET, Kung AW. Body fat determination by dual energy X-ray absorptiometry and its relation to body mass index and waist circumference in Hong Kong Chinese. Int J Obes Relat Metab Disord 2001; 25:748-52.
http://dx.doi.org/10.1038/sj.ijo.0801612
 
16. Norgan NG. Population differences in body composition in relation to the body mass index. Eur J Clin Nutr 1994; 48 suppl 3:S10-25; discussion S26-7.
 
17. Swinburn BA, Ley SJ, Carmichael HE, Plank LD. Body size and composition in Polynesians. Int J Obes Relat Metab Disord 1999; 23:1178-83.
http://dx.doi.org/10.1038/sj.ijo.0801053
 
18. Wang J, Thornton JC, Russel M, et al. Asians have lower body mass index (BMI) but higher percent body fat than do whites: comparisons of anthropometric measurements. Am J Clin Nutr 1994; 60:23-8.
 
19. Deurenberg-Yap M, Schmidt G, van Staveren WA and Deurenberg P. The paradox of low body mass index and high body fat percentage among Chinese, Malays and Indians in Singapore. Int J Obes Relat Metab Disord 2000; 24:1011-7.
http://dx.doi.org/10.1038/sj.ijo.0801353
 
20. Health Promotion Board Singapore. Revision of Body Mass Index (BMI) cut-offs in Singapore, 2005 [online]. Available at: www.hpb.gov.sg. Accessed May 15, 2012.
 
21. James AH, Tapson VF, Goldhaber SZ. Thrombosis during pregnancy and the postpartum period. Am J Obstet Gynecol 2005; 193:216-9.
http://dx.doi.org/10.1016/j.ajog.2004.11.037

Antenatally diagnosed congenital diaphragmatic hernia in Singapore: a five-year series

Share this Article

Singapore Med J 2013; 54(8): 432-436; http://dx.doi.org/10.11622/smedj.2013149. Addendum in: Singapore Med J 2013; 54(11): 661.
Antenatally diagnosed congenital diaphragmatic hernia in Singapore: a five-year series

Lee SY, Tan KH
Correspondence: Dr Lee Shu Yi Sonia, sonia.lee@mohh.com.sg

ABSTRACT
INTRODUCTION We aimed to investigate the epidemiology, diagnosis, prognostication, follow-up care and outcomes of antenatally diagnosed congenital diaphragmatic hernia (CDH) in KK Women’s and Children’s Hospital (KKH), Singapore. The objective of this study was to identify trends in current practice, and evaluate and improve the management of CDH.
METHODS We retrospectively reviewed cases of antenatally diagnosed CDH from 2006 to 2010.
RESULTS A total of 22 cases of CDH were found, bringing its incidence in KKH to 3.6 per 10,000 live births. The mean gestational age at diagnosis was 22.7 weeks, with 14 (63.6%) cases diagnosed at < 22 weeks and 8 (36.4%) diagnosed at ≥ 22 weeks. All cases were left-sided – 15 (68.2%) were isolated CDH and 7 (31.8%) were associated with other anomalies. Of the 22 cases, counselling about the prognosis of pregnancy based on the lung-to-head ratio was provided in 9 (40.9%). Overall, 10 (45.5%) cases resulted in termination of pregnancy (TOP), 9 (40.9%) resulted in live birth and 1 (4.5%) in stillbirth; 2 (9.1%) cases were lost to follow-up prior to delivery. Of the 9 live births, 3 (33.3%) resulted in neonatal death. In the 10 births, 5 (50.0%) were delivered by normal vaginal delivery, 4 (40.0%) by emergency Caesarean section and 1 (10.0%) by elective Caesarean section.
CONCLUSION CDH is a challenging perinatal problem with a low overall survival rate. Almost half of the cases opt for TOP. The data in this study can help clinicians better undertake the task of adequately counselling parents with qualitative and quantitative prognostic factors, using an evidence-based approach.

Keywords: antenatal diagnosis, congenital diaphragmatic hernia, epidemiology, outcome, prognosis
Singapore Med J 2013; 54(8): 432-436; http://dx.doi.org/10.11622/smedj.2013149

REFERENCES

1. Skari H, Bjomland K, Haugen G, Egeland T, Emblem R. Congenital diaphragmatic hernia: a meta-analysis of mortality factors. J Pediatr Surg 2000; 35:1187-97.
http://dx.doi.org/10.1053/jpsu.2000.8725
 
2. Thébaud B, Mercier JC, Dinh-Xuan AT. Congenital diaphragmatic hernia. A cause of persistent pulmonary hypertension of the newborn which lacks an effective therapy. Biol Neonate 1998; 74:323-36.
 
3. Fitzgibbons RJ, Greenburg AG, eds. Nyhus and Condon's Hernia. 5th ed. Philadelphia: Lippincott Williams & Wilkins, 2002.
 
4. Morgagni G. The Seats and Causes of Diseases Investigated by Anatomy. London: Millar and Cadell, 1960.
 
5. Game E, Haeusler M, Barisic I, et al. Congenital diaphragmatic hernia: evaluation of prenatal diagnosis in 20 European regions. Ultrasound Obstet Gynecol 2002; 19:329-33.
http://dx.doi.org/10.1046/j.1469-0705.2002.00635.x
 
6. Grisaru-Granovsky S, Rabinowitz R, Ioscovich A, Elstein D, Schimmel MS. Congenital diaphragmatic hernia: review of the literature in reflection of unresolved dilemmas. Acta Paediatr 2009; 98:1874-81.
http://dx.doi.org/10.1111/j.1651-2227.2009.01436.x
 
7. Beck C, Alkasi O, Nikischin W, et al. Congenital diaphragmatic hernia, etiology and management, a 10-year analysis of a single center. Arch Gynecol Obstet 2008; 277:55-63.
http://dx.doi.org/10.1007/s00404-007-0407-4
 
8. Romero R. Routine obstetric ultrasound. Ultrasound Obstet Gynecol 1993; 3:303-7.
http://dx.doi.org/10.1046/j.1469-0705.1993.03050303.x
 
9. Tan KH, Tan TY, Tan J, et al. Birth defects in Singapore: 1994-2000. Singapore Med J 2005; 46:545-52.
 
10. Jani J, Keller RL, Benachi A, et al. Prenatal prediction of survival in isolated left-sided diaphragmatic hernia. Ultrasound Obstet Gynecol 2006; 27:18-22.
http://dx.doi.org/10.1002/uog.2688
 
11. Wright JC, Budd JL, Field DJ, Draper ES. Epidemiology and outcome of congenital diaphragmatic hernia: a 9-year experience. Paediatr Perinat Epidemiol 2011; 25:144-9.
http://dx.doi.org/10.1111/j.1365-3016.2010.01172.x
 
12. Stege G, Fenton A, Jaffray B. Nihilism in the 1990s: the true mortality of congenital diaphragmatic hernia. Pediatrics 2003; 112:532-5.
http://dx.doi.org/10.1542/peds.112.3.532
 
13. Dillon E, Renwick M. Antenatal detection of congenital diaphragmatic hernias: the northern region experience. Clin Radiol 1993; 48:264-7.
http://dx.doi.org/10.1016/S0009-9260(05)81015-3
 
14. Kaiser JR, Rosenfeld CR. A population-based study of congenital diaphragmatic hernia: impact of associated anomalies and preoperative blood gases on survival. J Pediatr Surg 1999; 34:1196-202.
http://dx.doi.org/10.1016/S0022-3468(99)90151-3
 
15. Yang W, Carmichael SL, Harris JA, Shaw GM. Epidemiologic characteristics of congenital diaphragmatic hernia among 2.5 million California births, 1989-1997. Birth Defects Res A Clin Mol Teratol 2006; 76:170-4.
http://dx.doi.org/10.1002/bdra.20230
 
16. Dott MM, Wong LY, Rasmussen SA. Population-based study of congenital diaphragmatic hernia: risk factors and survival in Metropolitan Atlanta, 1968-1999. Birth Defects Res A Clin Mol Teratol 2003; 67:261-7.
http://dx.doi.org/10.1002/bdra.10039
 
17. Levison J, Halliday R, Holland AJ, et al for Neonatal Intensive Care Units Study of the NSW Pregnancy and Newborn Services Network. A population-based study of congenital diaphragmatic hernia outcome in New South Wales and the Australian Capital Territory, Australia, 1992-2001. J Pediatr Surg 2006; 41:1049-53.
http://dx.doi.org/10.1016/j.jpedsurg.2006.01.073
 
18. Colvin J, Bower C, Dickinson JE, Sokol J. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia. Pediatrics 2005; 116:356-63.
http://dx.doi.org/10.1542/peds.2004-2845
 
19. Shaw KS, Filiatrault D, Yazbeck S, St-Vil D. Improved survival for congenital diaphragmatic hernia, based on prenatal ultrasound diagnosis and referral to a combined obstetric-pediatric surgical center. J Pediatr Surg 1994; 29:1268-9.
http://dx.doi.org/10.1016/0022-3468(94)90821-4
 
20. Gallot D, Coste K, Francannet C, et al. Antenatal detection and impact on outcome of congenital diaphragmatic hernia: a 12-year experience in Auvergne, France. Eur J Obstet Gynecol Reprod Biol 2006; 125:202-5.
http://dx.doi.org/10.1016/j.ejogrb.2005.06.030
 
21. Okuyama H, Kitano Y, Saito M, et al. The Japanese experience with prenatally diagnosed congenital diaphragmatic hernia based on a multi-institutional review. Pediatr Surg Int 2011; 27:373-8.
http://dx.doi.org/10.1007/s00383-010-2805-0
 
22. Geary MP, Chitty LS, Morrison JJ, et al. Perinatal outcome and prognostic factors in prenatally diagnosed congenital diaphragmatic hernia. Ultrasound Obstet Gynecol 1998; 12:107-11.
http://dx.doi.org/10.1046/j.1469-0705.1998.12020107.x
 
23. Safavi A, Lin Y, Skarsgard ED; Canadian Pediatric Surgery Network. Perinatal management of congenital diaphragmatic hernia: when and how should babies be delivered? Results from the Canadian Pediatric Surgery Network. J Pediatr Surg 2010; 45:2334-9.
http://dx.doi.org/10.1016/j.jpedsurg.2010.08.026
 
24. Bétrémieux P, Lionnais S, Beuchée A, et al. Perinatal management and outcome of prenatally diagnosed congenital diaphragmatic hernia: a 1995-2000 series in Rennes University Hospital. Prenat Diagn 2002; 22:988-94.
http://dx.doi.org/10.1002/pd.454
 
25. Bedoyan JK, Blackwell SC, Treadwell MC, Johnson A, Klein MD. Congenital diaphragmatic hernia: associated anomalies and antenatal diagnosis. Outcome-related variables at two Detroit hospitals. Pediatr Surg Int 2004; 20:170-6.
http://dx.doi.org/10.1007/s00383-004-1138-2
 
26. Zaiss I, Kehl S, Link K, et al. Associated malformations in congenital diaphragmatic hernia. Am J Perinatol 2011; 28:211-8.
http://dx.doi.org/10.1055/s-0030-1268235
 
27. Fauza DO, Wilson JM. Congenital diaphragmatic hernia and associated anomalies: their incidence, identification and impact on prognosis. J Pediatr Surg 1994; 29:1113-7.
http://dx.doi.org/10.1016/0022-3468(94)90290-9
 
28. Lipshutz GS, Albanese CT, Feldstein VA, et al. Prospective analysis of lung-to-head ratio predicts survival for patients with prenatally diagnosed congenital diaphragmatic hernia. J Pediatr Surg 1997; 32:1634-6.
http://dx.doi.org/10.1016/S0022-3468(97)90471-1
 
29. Flake AW, Crombleholme TM, Johnson MP, Howell LJ, Adzick NS. Treatment of severe congenital diaphragmatic hernia by fetal tracheal occlusion: clinical experience with fifteen cases. Am J Obstet Gynecol 2000; 183:1059-66.
http://dx.doi.org/10.1067/mob.2000.108871
 
30. Laudy JA, Van Gucht M, Van Dooren MF, Wladimiroff JW, Tibboel D. Congenital diaphragmatic hernia: an evaluation of the prognostic value of the lung-to-head ratio and other prenatal parameters. Prenat Diagn 2003; 23:634-9.
http://dx.doi.org/10.1002/pd.654
 
31. Ba'ath ME, Jesudason EC, Losty PD. How useful is the lung-to-head ratio in predicting outcome in the fetus with congenital diaphragmatic hernia? A systematic review and meta-analysis. Ultrasound Obstet Gynecol 2007; 30:897-906.
http://dx.doi.org/10.1002/uog.5164
 
32. Jani J, Nicolaides KH, Benachi A, et al. Timing of lung size assessment in the prediction of survival in fetuses with diaphragmatic hernia. Ultrasound Obstet Gynecol 2008; 31:37-40.
http://dx.doi.org/10.1002/uog.5198
 
33. Adzick NS, Harrison MR, Glick PL, et al. Diaphragmatic hernia in the fetus: prenatal diagnosis and outcome in 94 cases. J Pediatr Surg 1985; 20:357-61.
http://dx.doi.org/10.1016/S0022-3468(85)80219-0
 
34. Thorpe-Beeston JG, Gosden CM, Nicolaides KH. Prenatal diagnosis of congenital diaphragmatic hernia: associated malformations and chromosomal defects. Fetal Ther 1989; 4:21-8.
http://dx.doi.org/10.1159/000263386
 
35. Brownlee EM, Howatson AG, Davis CF, Sabharwal AJ. The hidden mortality of congenital diaphragmatic hernia: a 20-year review. J Pediatr Surg 2009; 44:317-20.
http://dx.doi.org/10.1016/j.jpedsurg.2008.10.076
 

A prospective study of risk factors for first trimester miscarriage in Asian women with threatened miscarriage

Share this Article

Singapore Med J 2013; 54(8): 425-431; http://dx.doi.org/10.11622/smedj.2013148
A prospective study of risk factors for first trimester miscarriage in Asian women with threatened miscarriage

Kouk LJ, Neo GH, Malhotra R, Allen JC, Beh ST, Tan TC, Østbye T
Correspondence: Prof Truls Østbye, truls.ostbye@duke-nus.edu.sg

ABSTRACT
INTRODUCTION The present study aimed to assess the demographic, socioeconomic, medical and lifestyle factors associated with the progression of a threatened miscarriage to a complete miscarriage in the first trimester.
METHODS A prospective cohort study was conducted on 157 women who presented with vaginal bleeding in the fifth to tenth week of gestation. Cox regression analysis was used to determine the risk factors for progression to a complete miscarriage within 16 weeks of gestation.
RESULTS Of the 139 women included for data analysis, 36 (25.9%) had a miscarriage, mostly within two weeks of presentation. The results of our study showed that women aged ≥ 34 years were more likely to miscarry (hazard ratio [HR] = 1.95). Compared to women whose partner was 20–30 years of age, women whose partner was ≥ 41 years of age also had a higher likelihood of experiencing a miscarriage (HR = 8.33). However, the presence of nausea (HR = 0.33) and a high stress score (i.e. ≥ 17) on the Perceived Stress Scale (HR = 0.49) were associated with a reduced likelihood of miscarriage.
CONCLUSION Older pregnant women experiencing a threatened miscarriage should be counselled about their higher risk of miscarriage, especially if they have an older partner.

Keywords: maternal age, nausea, paternal age, Southeastern Asia, threatened abortion
Singapore Med J 2013; 54(8): 425-431; http://dx.doi.org/10.11622/smedj.2013148

REFERENCES

1. Everett C. Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice. BMJ 1997; 315: 32-4.
http://dx.doi.org/10.1136/bmj.315.7099.32
 
2. Weiss JL, Malone FD, Vidaver J, et al. Threatened abortion: A risk factor for poor pregnancy outcome, a population-based screening study. Am J Obstet Gynecol 2004; 190:745-50.
http://dx.doi.org/10.1016/j.ajog.2003.09.023
 
3. Basama FM, Crosfill F. The outcome of pregnancies in 182 women with threatened miscarriage. Arch Gynecol Obstet 2004; 270:86-90.
http://dx.doi.org/10.1007/s00404-003-0475-z
 
4. Davari-Tanha F, Shariat M, Kaveh M, Ebrahimi M, Jalalvand S. Threatened abortion: A risk factor for poor pregnancy outcome. Acta Med Iran 2008; 46:314-20.
 
5. El-Zibdeh MY, Yousef LT. Dydrogesterone support in threatened miscarriage. Maturitas 2009; 65 suppl 1: S43-6.
http://dx.doi.org/10.1016/j.maturitas.2009.11.013
 
6. Tongsong T, Srisomboon J, Wanapirak C, et al. Pregnancy outcome of threatened abortion with demonstrable fetal cardiac activity: a cohort study. J Obstet Gynaecol (Tokyo 1995) 1995; 21:331-5.
http://dx.doi.org/10.1111/j.1447-0756.1995.tb01019.x
 
7. Johns J, Hyett J, Jauniaux E. Obstetric outcome after threatened miscarriage with and without a hematoma on ultrasound. Obstet Gynecol 2003; 102:483-7.
http://dx.doi.org/10.1016/S0029-7844(03)00580-5
 
8. Johns J, Jauniaux E. Threatened miscarriage as a predictor of obstetric outcome. Obstet Gynecol 2006; 107:845-50.
http://dx.doi.org/10.1097/01.AOG.0000206186.91335.9a
 
9. Wijesiriwardana A, Bhattacharya S, Shetty A, Smith N. Obstetric outcome in women with threatened miscarriage in the first trimester. Obstet Gynecol 2006; 107: 557-62.
http://dx.doi.org/10.1097/01.AOG.0000199952.82151.de
 
10. Saraswat L, Bhattacharya S, Maheshwari A, Bhattacharya S. Maternal and perinatal outcome in women with threatened miscarriage in the first trimester: a systematic review. BJOG: 2010; 117:245-57.
http://dx.doi.org/10.1111/j.1471-0528.2009.02427.x
 
11. Lashen H, Fear K, Sturdee DW. Obesity is associated with increased risk of first trimester and recurrent miscarriage: matched case-control study. Hum Reprod 2004; 19:1644-6.
http://dx.doi.org/10.1093/humrep/deh277
 
12. Maconochie N, Doyle P, Prior S, Simmons R. Risk factors for first trimester miscarriage--results from a UK-population-based case-control study. BJOG 2007; 114:170-86.
http://dx.doi.org/10.1111/j.1471-0528.2006.01193.x
 
13. Ong CY, Liao AW, Spencer K, Munim S, Nicolaides KH. First trimester maternal serum free beta human chorionic gonadotrophin and pregnancy associated plasma protein A as predictors of pregnancy complications. BJOG 2000; 107:1265-70.
http://dx.doi.org/10.1111/j.1471-0528.2000.tb11618.x
 
14. Sugiyama T, Watanabe H, Takimoto H, et al. Management of obesity in pregnancy. Curr Womens Health Rev 2009; 5:220-4.
http://dx.doi.org/10.2174/157340409790069970
 
15. Weng X, Odouli R, Li DK. Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study. Am J Obstet Gynecol 2008; 198: 279.e1-8.
 
16. Madsen M, Jorgensen T, Jensen ML, et al. Leisure time physical exercise during pregnancy and the risk of miscarriage: a study within the Danish National Birth Cohort. BJOG 2007; 114:1419-26.
http://dx.doi.org/10.1111/j.1471-0528.2007.01496.x
 
17. Arck PC, Rose M, Hertwig K, et al. Stress and immune mediators in miscarriage. Hum Reprod 2001; 16:1505-11.
http://dx.doi.org/10.1093/humrep/16.7.1505
 
18. George L, Granath F, Johansson AL, Annerén G, Cnattingius S. Environmental tobacco smoke and risk of spontaneous abortion. Epidemiology 2006; 17:500-5.
http://dx.doi.org/10.1097/01.ede.0000229984.53726.33
 
19. Venners SA, Wang X, Chen C, et al. Paternal smoking and pregnancy loss: a prospective study using a biomarker of pregnancy. Am J Epidemiol 2004; 159:993-1001.
http://dx.doi.org/10.1093/aje/kwh128
 
20. Kesmodel U, Wisborg K, Olsen SF, Henriksen TB, Secher NJ. Moderate alcohol intake in pregnancy and the risk of spontaneous abortion. Alcohol Alcohol 2002; 37:87-92.
http://dx.doi.org/10.1093/alcalc/37.1.87
 
21. Windham GC, Fenster L, Swan SH. Moderate maternal and paternal alcohol consumption and the risk of spontaneous abortion. Epidemiology 1992; 3:364-70.
http://dx.doi.org/10.1097/00001648-199207000-00012
 
22. Han HC, Tan KH. A clinical study of the prognosis and outcome of first trimester threatened abortion. The Singapore Family Physician 1992; 18:35-44.
 
23. Sotiriadis A, Papatheodorou S, Makrydimas G. Threatened miscarriage: evaluation and management. BMJ 2004; 329:152-5.
http://dx.doi.org/10.1136/bmj.329.7458.152
 
24. Arck PC, Rücke M, Rose M, et al. Early risk factors for miscarriage: a prospective cohort study in pregnant women. Reprod Biomed Online 2008; 17:101-13.
http://dx.doi.org/10.1016/S1472-6483(10)60300-8
 
25. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav 1983; 24:385-96.
http://dx.doi.org/10.2307/2136404
 
26. Cohen S, Lichtenstein E. Perceived stress, quitting smoking, and smoking relapse.Health Psychol 1990; 9:466-78.
http://dx.doi.org/10.1037/0278-6133.9.4.466
 
27. Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med 1991; 325:606-12.
http://dx.doi.org/10.1056/NEJM199108293250903
 
28. Sellers RM, Caldwell CH, Schmeelk-Cone KH, Zimmerman MA. Racial identity, racial discrimination, perceived stress, and psychological distress among African American young adults. J Health Soc Behav 2003; 44:302-17.
http://dx.doi.org/10.2307/1519781
 
29. Mimura C, Griffiths P. A Japanese version of the perceived stress scale: translation and preliminary test. Int J Nurs Stud 2004; 41:379-85.
http://dx.doi.org/10.1016/j.ijnurstu.2003.10.009
 
30. Pbert L, Doerfler LA, DeCosimo D. An evaluation of the perceived stress scale in two clinical populations. J Psychopathol Behav Assess 1992; 14:363-75.
http://dx.doi.org/10.1007/BF00960780
 
31. Reis RS, Hino AA, A-ez CR. Perceived stress scale: reliability and validity study in Brazil. J Health Psychol 2010; 15:107-14.
http://dx.doi.org/10.1177/1359105309346343
 
32. Leung DY, Lam TH, Chan SS. Three versions of Perceived Stress Scale: validation in a sample of Chinese cardiac patients who smoke. BMC Public Health 2010; 10:513.
http://dx.doi.org/10.1186/1471-2458-10-513
 
33. Lau Y, Yin L. Maternal, obstetric variables, perceived stress and healthrelated quality of life among pregnant women in Macao, China. Midwifery 2011; 27:668-73.
http://dx.doi.org/10.1016/j.midw.2010.02.008
 
34. Gao LL, Chan SW, Mao Q. Depression, perceived stress, and social support among first-time Chinese mothers and fathers in the postpartum period. Res Nurs Health 2009; 32:50-8.
http://dx.doi.org/10.1002/nur.20306
 
35. Lu H, Zhu X, Hou R, et al. Chinese family adaptation during the postpartum period and its influencing factors: A questionnaire survey. Midwifery 2012; 28:222-7.
http://dx.doi.org/10.1016/j.midw.2011.01.004
 
36. Keim SA, Daniels JL, Dole N, et al. A prospective study of maternal anxiety, perceived stress, and depressive symptoms in relation to infant cognitive development. Early Hum Dev 2011; 87:373-80.
http://dx.doi.org/10.1016/j.earlhumdev.2011.02.004
 
37. Rondó PH, Ferreira RF, Nogueira F, et al. Maternal psychological stress and distress as predictors of low birth weight, prematurity and intrauterine growth retardation. Eur J Clin Nutr 2003; 57:266-72.
http://dx.doi.org/10.1038/sj.ejcn.1601526
 
38. Glynn LM, Schetter CD, Hobel CJ, Sandman CA. Pattern of perceived stress and anxiety in pregnancy predicts preterm birth. Health Psychol 2008; 27:43-51.
http://dx.doi.org/10.1037/0278-6133.27.1.43
 
39. Vythilingum B, Geerts L, Fincham D, et al. Association between antenatal distress and uterine artery pulsatility index. Arch Womens Ment Health 2010; 13:359-64.
http://dx.doi.org/10.1007/s00737-010-0144-8
 
40. Omar MH, Mashita MK, Lim PS, Jamil MA. Dydrogesterone in threatened abortion: pregnancy outcome. J Steroid Biochem Mol Biol 2005; 97:421-5.
http://dx.doi.org/10.1016/j.jsbmb.2005.08.013
 
41. Goodwin TM, Hershman JM, Cole L. Increased concentration of the free beta-subunit of human chorionic gonadotropin in hyperemesis gravidarum. Acta Obstet Gynecol Scand 1994; 73:770-2.
http://dx.doi.org/10.3109/00016349409072502
 
42. Gracia CR, Sammel MD, Chittams J, et al. Risk factors for spontaneous abortion in early symptomatic first-trimester pregnancies. Obstet Gynecol 2005; 106:993-9.
http://dx.doi.org/10.1097/01.AOG.0000183604.09922.e0
 
43. Furneaux EC, Langley-Evans AJ, Langley-Evans SC. Nausea and vomiting of pregnancy: endocrine basis and contribution to pregnancy outcome. Obstet Gynecol Surv 2001; 56:775-82.
http://dx.doi.org/10.1097/00006254-200112000-00004
 
44. Yaron Y, Ochshorn Y, Heifetz S, et al. First trimester maternal serum free human chorionic gonadotropin as a predictor of adverse pregnancy outcome. Fetal Diagn Ther 2002; 17:352-6.
http://dx.doi.org/10.1159/000065384
 
45. Cleary-Goldman J, Malone FD, Vidaver J, et al. Impact of maternal age on obstetric outcome. Obstet Gynecol 2005; 105:983-90.
http://dx.doi.org/10.1097/01.AOG.0000158118.75532.51
 
46. de la Rochebrochard E, Thonneau P. Paternal age and maternal age are risk factors for miscarriage; results of a multicentre European study. Hum Reprod 2002; 17:1649-56.
http://dx.doi.org/10.1093/humrep/17.6.1649
 
47. de La Rochebrochard E, Thonneau P. Paternal age >or=40 years: an important risk factor for infertility. Am J Obstet Gynecol 2003; 189:901-5.
http://dx.doi.org/10.1067/S0002-9378(03)00753-1
 
48. Cohen S. Perceived stress in a probability sample of the United States. In: Spacapan S, Oskamp S, eds. The social psychology of health. CA: Sage Publications, 1988: p.31-67.
 
49. Kalinka J, Szekeres-Bartho J. The impact of dydrogesterone supplementation on hormonal profile and progesterone-induced blocking factor concentrations in women with threatened abortion. Am J Reprod Immunol 2005; 53:166-71.
http://dx.doi.org/10.1111/j.1600-0897.2005.00261.x
 
50. Mimura C, Griffiths P. A Japanese version of the Perceived Stress Scale: crosscultural translation and equivalence assessment. BMC Psychiatry 2008; 8:85.
http://dx.doi.org/10.1186/1471-244X-8-85
 
51. Lok CF, Bishop GD. Emotion control, stress, and health. Psychol Health 1999; 14:813-27.
http://dx.doi.org/10.1080/08870449908407349
 
52. Lee KM, Manning V, Teoh HC, et al. Stress-coping morbidity among family members of addiction patients in Singapore. Drug Alcohol Rev 2011; 30:441-7.
http://dx.doi.org/10.1111/j.1465-3362.2011.00301.x

Relationship between thyroid-stimulating hormone and blood pressure in the middle-aged and elderly population

Share this Article

Singapore Med J 2013; 54(7): 401-405; http://dx.doi.org/10.11622/smedj.2013142
Relationship between thyroid-stimulating hormone and blood pressure in the middle-aged and elderly population

Jian WX, Jin J, Qin L, Fang WJ, Chen XR, Chen HB, Su Q, Xing HL
Correspondence: Prof Hui-Li Xing, dr_huilixing@126.com

ABSTRACT
Introduction Hypothyroidism and subclinical hypothyroidism may be associated with hypertension and metabolic syndrome. The aim of this study was to investigate the relationship between thyroid-stimulating hormone (TSH) and blood pressure, as well as the relationship between thyroid function and insulin resistance in middle-aged and elderly Chinese.
Methods This was a cross-sectional, community-based study. Serum TSH, fasting glucose and insulin were measured in 2,988 subjects aged 35–80 years. Logistic regression analysis was used to identify the risk factors for hypertension. Analysis of variance and multiple linear regression analysis were performed to characterise the relationship among TSH, insulin resistance and blood pressure.
Results Higher serum TSH concentration was found to be an independent risk factor for hypertension in females (odds ratio 1.4, 95% confidence interval 1.02–1.93; p-value = 0.039). The female group with subclinical hypothyroidism and high normal TSH (2.5–4.8 mIU/L) were more susceptible to high blood pressure than those with low normal TSH (0.3–2.5 mIU/L) (p-value < 0.05). After adjustment for waist-hip ratio and body mass index, neither the correlation between blood pressure and homeostasis model assessment of insulin resistance (HOMA-IR) nor the correlation between TSH and HOMA-IR were found to be significant in this study.
Conclusion This study provides evidence that both subclinical hypothyroidism and high normal TSH are independent risk factors for hypertension in middle-aged and elderly Chinese women.

Keywords: hypertension, hypothyroidism, insulin resistance, thyrotropin
Singapore Med J 2013; 54(7): 401-405; http://dx.doi.org/10.11622/smedj.2013142

REFERENCES

1. Danzi S, Klein I. Thyroid hormone and blood pressure regulation. Curr Hypertens Rep 2003; 5:513-20.
http://dx.doi.org/10.1007/s11906-003-0060-7
 
2. Klein I, Danzi S. Thyroid disease and the heart. Circulation 2007; 116:1725-35.
http://dx.doi.org/10.1161/CIRCULATIONAHA.106.678326
 
3. Asvold BO, Bjøro T, Nilsen TI, Vatten LJ. Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study. J Clin Endocrinol Metab 2007; 92:841-5.
http://dx.doi.org/10.1210/jc.2006-2208
 
4. Ruhla S, Weickert MO, Arafat AM, et al. A high normal TSH is associated with the metabolic syndrome. Clin Endocrinol (Oxf) 2010; 72:696-701.
http://dx.doi.org/10.1111/j.1365-2265.2009.03698.x
 
5. Taddei S, Caraccio N, Virdis A, et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 2003; 88:3731-7.
http://dx.doi.org/10.1210/jc.2003-030039
 
6. Walsh JP, Bremner AP, Bulsara MK, et al. Subclinical thyroid dysfunction and blood pressure: a community-based study. Clin Endocrinol (Oxf) 2006; 65:486-91.
http://dx.doi.org/10.1111/j.1365-2265.2006.02619.x
 
7. Kawamoto R, Kohara K, Tabara Y, et al. Insulin resistance and prevalence of prehypertension and hypertension among communitydwelling persons. J Atheroscler Thromb 2010; 17:148-55.
http://dx.doi.org/10.5551/jat.2584
 
8. Sung KC, Kim BJ, Kim BS, et al. In normoglycemic Koreans, insulin resistance and adipocity are independently correlated with high blood pressure. Circ J 2004; 68:898-902.
http://dx.doi.org/10.1253/circj.68.898
 
9. Boucai L, Surks MI. Reference limits of serum TSH and free T4 are significantly influenced by race and age in an urban outpatient medical practice. Clin Endocrinol (Oxf) 2009; 70:788-93.
http://dx.doi.org/10.1111/j.1365-2265.2008.03390.x
 
10. Wartofsky L, Dickey RA. The evidence for a narrower thyrotropin reference range is compelling. J Clin Endocrinol Metab 2005; 90:5483-8.
http://dx.doi.org/10.1210/jc.2005-0455
 
11. Liu D, Jiang F, Shan Z, et al. A cross-sectional survey of relationship between serum TSH level and blood pressure. J Hum Hypertens 2010; 24:134-8.
http://dx.doi.org/10.1038/jhh.2009.44
 
12. Fommei E, Iervasi G. The role of thyroid hormone in blood pressure homeostasis: evidence from short-term hypothyroidism in humans. J Clin Endocrinol Metab 2002; 87:1996-2000.
http://dx.doi.org/10.1210/jc.87.5.1996
 
13. Dickey RA, Wartofsky L, Feld S. Optimal thyrotropin level: normal ranges and reference intervals are not equivalent. Thyroid 2005; 15:1035-9.
http://dx.doi.org/10.1089/thy.2005.15.1035
 
14. Fernández-Real JM, López-Bermejo A, Castro A, Casamitjana R, Ricart W. Thyroid function is intrinsically linked to insulin sensitivity and endothelium-dependent vasodilation in healthy euthyroid subjects. J Clin Endocrinol Metab 2006; 91:3337-43.
http://dx.doi.org/10.1210/jc.2006-0841
 
15. Iqbal A, Figenschau Y, Jorde R. Blood pressure in relation to serum thyrotropin: The Tromsø study. J Hum Hypertens 2006; 20:932-6.
http://dx.doi.org/10.1038/sj.jhh.1002091
 
16. Gumieniak O, Hurwitz S, Perlstein TS, et al. Aggregation of high-normal thyroid-stimulating hormone in hypertensive families. J Clin Endocrinol Metab 2005; 90:5985-90.
http://dx.doi.org/10.1210/jc.2005-0373
 
17. De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R. Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol (Oxf) 2007; 67:265-9.
http://dx.doi.org/10.1111/j.1365-2265.2007.02874.x
 
18. Park HT, Cho GJ, Ahn KH, et al. Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women. Maturitas 2009; 62:301-5.
http://dx.doi.org/10.1016/j.maturitas.2009.01.007

Type 1 and type 2 diabetes mellitus: are they mutually exclusive?

Share this Article

Singapore Med J 2013; 54(7): 396-400; http://dx.doi.org/10.11622/smedj.2013141
Type 1 and type 2 diabetes mellitus: are they mutually exclusive?

Fatima A, Khawaja KI, Burney S, Minhas K, Mumtaz U, Masud F
Correspondence: Dr Faisal Masud, dr.faisalmasud@gmail.com

ABSTRACT
Introduction With advancement in the understanding of the pathogenesis underlying diabetes mellitus (DM), the boundary between type 1 and type 2 DM (T1DM and T2DM) does not seem to be as clear cut as previously thought. This study was designed to test the possibility of overlap between the spectra of immune-mediated DM and insulin resistance.
Methods To test for the possibility of overlap, we looked for autoantibodies typical of T1DM in patients with classical T2DM, and insulin resistance in patients with T1DM. Autoantibodies against islet cell antigen, glutamic acid decarboxylase-65 and insulinoma-associated antigen-2 were tested in 82 patients with T2DM and 27 patients with T1DM. The patients had been diagnosed on clinical criteria using standard laboratory techniques. Clinical parameters of diagnostic importance were noted, and homeostatic model assessment of insulin resistance (HOMA-IR) was calculated using fasting insulin and fasting blood glucose ratio.
Results Autoantibodies against one or more beta cell antigens were detected in 12.19% of patients clinically diagnosed to have T2DM, and insulin resistance (HOMA-IR > 2.5) was diagnosed in 37.03% of patients with T1DM. It was not possible to identify any combination of clinical or biochemical markers that could predict autoantibody positivity in T2DM patients. T1DM patients with insulin resistance had a significantly higher body mass index than their insulin-sensitive counterparts (p = 0.02).
Conclusion Autoantibodies against beta cell antigens are detectable in insulin-resistant T2DM patients, and insulin resistance may be present in relatively overweight T1DM patients. No differentiating clinical features that might predict autoantibody positivity in T2DM patients were found.

Keywords: autoantibodies, insulin resistance, type 1 diabetes mellitus, type 2 diabetes mellitus
Singapore Med J 2013; 54(7): 396-400; http://dx.doi.org/10.11622/smedj.2013141

REFERENCES

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35 Suppl 1:64-71.
http://dx.doi.org/10.2337/dc12-s064
 
2. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-9.
http://dx.doi.org/10.1007/BF00280883
 
3. Brooks-Worrell B, Palmer JP. Is diabetes mellitus a continuous spectrum? Clin Chem 2011; 57:158-61.
http://dx.doi.org/10.1373/clinchem.2010.148270
 
4. Tsui H, Paltser G, Chan Y, Dorfman R, Dosch HM. 'Sensing' the link between type 1 and type 2 diabetes. Diabetes Metab Res Rev 2011; 27:913-8.
http://dx.doi.org/10.1002/dmrr.1279
 
5. Nadeau KJ, Regensteiner JG, Bauer TA et al. Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function. J Clin Endocrinol Metab 2010; 95:513-21.
http://dx.doi.org/10.1210/jc.2009-1756
 
6. Brooks-Worrell B, Palmer JP. Immunology in the Clinic Review Series; focus on metabolic diseases: development of islet autoimmune disease in type 2 diabetes patients: potential sequelae of chronic inflammation. Clin Exp Immunol 2012; 167:40-6.
http://dx.doi.org/10.1111/j.1365-2249.2011.04501.x
 
7. Negishi M, Shimomura K, Proks P, et al. An obese patient with slowly progressive type 1 diabetes diagnosed by ketoacidosis. Intern Med 2010; 49:393-5.
http://dx.doi.org/10.2169/internalmedicine.49.2843
 
8. Nambam B, Aggarwal S, Jain A. Latent autoimmune diabetes in adults: A distinct but heterogeneous clinical entity. World J Diabetes 2010; 1:111-5.
http://dx.doi.org/10.4239/wjd.v1.i4.111
 
9. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Brussels: International Diabetes Federation, 2006.
 
10. Friedrich N, Thuesen B, Jørgensen T, et al. The association between IGF-1 and insulin resistance: a general population study in Danish adults. Diabetes Care 2012; 35:768-73.
http://dx.doi.org/10.2337/dc11-1833
 
11. Alberti G, Zimmet P, Shaw J, et al. Type 2 diabetes in the young: the evolving epidemic: the international diabetes federation consensus workshop. Diabetes Care 2004; 27:1798-811.
http://dx.doi.org/10.2337/diacare.27.7.1798
 
12. LaFontaine T. Physical Activity: The Epidemic of Obesity and Overweight Among Youth: Trends, Consequences, and Interventions. American Journal of Lifestyle Medicine 2008; 2:30-36.
http://dx.doi.org/10.1177/1559827607309688
 
13. Suzuki T, Takahashi K, Miyamoto S, et al. "Type 1 on type 2" diabetes mellitus: autoimmune type 1 diabetes superimposed on established type 2 diabetes. Intern Med 2007; 46:1957-62.
http://dx.doi.org/10.2169/internalmedicine.46.0282
 
14. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27:1487-95.
http://dx.doi.org/10.2337/diacare.27.6.1487
 
15. Szadkowska A, Pietrzak I, Bodalska-Lipi?ska J, et al. [Insulin resistance in young type 1 diabetic patients]. Diabetologia Do?wiadczalna i Kliniczna 2006; 6:293-8. Polish.
 
16. Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP; Diabetes Prevention Trial-Type 1 Study Group. Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 2007; 30:2314-20.
http://dx.doi.org/10.2337/dc06-2389
 
17. Pozzilli P, Guglielmi C, Caprio S, Buzzetti R. Obesity, autoimmunity, and double diabetes in youth. Diabetes Care 2011; 34 Suppl 2:166-70.
http://dx.doi.org/10.2337/dc11-s213
 
18. Verge CF, Gianani R, Kawasaki E, et al. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type 1 diabetes. J Autoimmun 1996; 9:379-83.
http://dx.doi.org/10.1006/jaut.1996.0051
 
19. Winter WE, Harris N, Schatz D. Immunologic markers in the diagnosis and prediction of autoimmune, type 1A diabetes. Clinical Diabetes 2002; 20:183-91.
http://dx.doi.org/10.2337/diaclin.20.4.183
 
20. Falorni A, Brozzetti A. Diabetes-related antibodies in adult diabetic patients. Best Pract Res Clin Endocrinol Metab 2005; 19:119-33.
http://dx.doi.org/10.1016/j.beem.2004.11.010
 
21. Zimmet PZ, Tuomi T, Mackay IR. Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 1994; 11:299-303.
http://dx.doi.org/10.1111/j.1464-5491.1994.tb00275.x
 
22. Bottazzo GF, Bosi E, Cull CA, et al. IA-2 antibody prevalence and risk assessment of early insulin requirement in subjects presenting with type 2 diabetes (UKPDS 71). Diabetologia 2005; 4:703-8.
http://dx.doi.org/10.1007/s00125-005-1691-9
 
23. Winter WE, Schatz DA. Autoimmune markers in diabetes. Clin Chem 2011; 57:168-75.
http://dx.doi.org/10.1373/clinchem.2010.148205
 
24. Juneja R, Hirsch IB, Naik RG, et al. Islet cell antibodies and glutamic acid decarboxylase antibodies, but not the clinical phenotype, help to identify type 1(1/2) diabetes in patients presenting with type 2 diabetes. Metabolism 2001; 50:1008-13.
http://dx.doi.org/10.1053/meta.2001.25654
 
25. Turner R, Stratton I, Horton V, et al. Autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes (UKPDS 25). Lancet 1997; 350:1288-93.
http://dx.doi.org/10.1016/S0140-6736(97)03062-6
 
26. Borg H, Gottsäter A, Fernlund P, Sundkvist G. A 12-year prospective study of the relationship between islet antibodies and beta-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 2002; 51:1754-62.
http://dx.doi.org/10.2337/diabetes.51.6.1754
 
27. Borg H, Gottsäter A, Landin-Olsson M, Fernlund P, Sundkvist G. High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age. J Clin Endocrinol Metab 2001; 86:3032-8.
http://dx.doi.org/10.1210/jc.86.7.3032
 
28. Kobayashi T, Nakanishi K, Murase T, Kosaka K. Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 1996; 45:622-6.
http://dx.doi.org/10.2337/diabetes.45.5.622
 
29. Anastasi E, Dotta F, Tiberti C, et al. Insulin prophylaxis down-regulates islet antigen expression and islet autoimmunity in the low-dose Stz mouse model of diabetes. Autoimmunity 1995; 29:249-56.
http://dx.doi.org/10.3109/08916939908994743

Usage of glucometer is associated with improved glycaemic control in type 2 diabetes mellitus patients in Malaysian public primary care clinics: an open-label, randomised controlled trial

Share this Article

Singapore Med J 2013; 54(7): 391-395; http://dx.doi.org/10.11622/smedj.2013140; Erratum in: Singapore Med J 2013; 54(8): 474.
Usage of glucometer is associated with improved glycaemic control in type 2 diabetes mellitus patients in Malaysian public primary care clinics: an open-label, randomised controlled trial

Mastura I, Teng CL, Mimi O, Ho BK, Kusiar Z, Hasim R
Correspondence: Dr Mastura Ismail, drmi68@yahoo.com

ABSTRACT
Introduction Self-monitoring of blood glucose (SMBG) has been underutilised. We conducted an open-label, randomised controlled trial to assess the feasibility of introducing SMBG in primary care clinics in Malaysia.
Methods This was an open-label, randomised controlled trial conducted in five public primary care clinics in Malaysia. Patients with type 2 diabetes mellitus (age range 35–65 years) not performing SMBG at the time of the study were randomised to receive either a glucometer for SMBG or usual care. Both groups of patients received similar diabetes care from the clinics.
Results A total of 105 patients with type 2 diabetes mellitus were enrolled. Of these, 58 and 47 were randomised to intervention and control groups, respectively. After six months, the glycated haemoglobin (HbA1c) level in the intervention group showed a statistically significant improvement of 1.3% (p = 0.001; 95% confidence interval 0.6–2.0), relative to the control group that underwent usual care. The percentages of patients that reached the HbA1c treatment target of ≤ 7% were 14.0% and 32.1% in the control and intervention groups (p = 0.036), respectively.
Conclusion The usage of a glucometer improved glycaemic control, possibly due to the encouragement of greater self-care in the intervention group.

Keywords: diabetes mellitus, Malaysia, primary care, randomised controlled trial, self-monitoring of blood glucose
Singapore Med J 2013; 54(7): 391-395; http://dx.doi.org/10.11622/smedj.2013140

REFERENCES

1. Ministry of Health, Malaysia. The Third National Health Morbidity Survey (NHMS III) Diabetes Group. Malaysia: Ministry of Health, 2006.
 
2. Mastura I, Chew BH, Lee PY, et al. Control and Treatment Profiles of 70,889 Adult Type 2 Diabetes Mellitus Patients in Malaysia - A Cross Sectional Survey in 2009. Int J Collaborative Res Intern Med Public Health 2011; 3:98-113.
 
3. Mafauzy M, Hussein Z, Chan SP. The status of diabetes control in Malaysia: results of Diabcare 2008. Med J Malaysia 2011; 66:175-81.
 
4. Haliza AM, Roslan Johari MG, Badrulnizam M, et al. Management of Patients with Type II Diabetes Mellitus in MOH Hospitals and Health Centres. J Health Manage 2006; 4:73-87.
 
5. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complication in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-53. Erratum in: Lancet 1999; 354:602.
http://dx.doi.org/10.1016/S0140-6736(98)07019-6
 
6. American Association of Clinical Endocrinologists. The American Association of Clinical Endocrinologists Medical Guidelines for the Management of Diabetes Mellitus: the AACE system of intensive diabetes self-management--2002 update. Endocr Pract 2002; 8 suppl 1:40-82.
http://dx.doi.org/10.4158/EP.8.S1.40
 
7. Guerci B, Drouin P, Grange V, et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003; 29:587-94.
http://dx.doi.org/10.1016/S1262-3636(07)70073-3
 
8. Karter A, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001; 111:1-9.
http://dx.doi.org/10.1016/S0002-9343(01)00742-2
 
9. Charuruks N, Surasiengsunk S, Suwanwalaikorn S, et al. Impact of Self-monitoring of Blood Glucose in Diabetic Patients in Thailand. Point Care: J Near-Patient Test Technol 2006; 5:155-9.
http://dx.doi.org/10.1097/01.poc.0000243979.85019.cb
 
10. Kibriya MG, Ali L, Banik NG, Khan AK. Home monitoring of blood glucose (HMBG) in Type-2 diabetes mellitus in a developing country. Diabetes Res Clin Pract 1999; 46:253-7.
http://dx.doi.org/10.1016/S0168-8227(99)00093-5
 
11. Chidum E, Agbai D, Fidelis O, et al. Self-monitoring of blood glucose improved glycaemic control and 10-year coronary heart disease risk profile of type 2 diabetic patients. Chin Med J (Engl) 2011; 124:166-71.
 
12. Clinical Practice Guidelines Task Force. Clinical Practice Guidelines: Management of Type 2 Diabetes Mellitus. 4th ed. Malaysia: Ministry of Health, 2009.
 
13. Campbell MJ, Julious SA, Altman DG. Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ 1995; 311:1145-8.
http://dx.doi.org/10.1136/bmj.311.7013.1145
 
14. Welschen LM, Bloemendal E, Nijpels G, et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systemic review. Diabetes Care 2005; 28:1510-7.
http://dx.doi.org/10.2337/diacare.28.6.1510
 
15. Fontbonne A, Billault B, Acosta M, et al. Is glucose self-monitoring beneficial in non-insulin- treated diabetic patients? Results of a randomized comparative trial. Diabetes Metab 1989; 15:255-60.
 
16. Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol 1994; 31:215-9.
http://dx.doi.org/10.1007/BF00571954
 
17. Allen BT, DeLong ER, Feussner JR. Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing. Diabetes Care 1990; 13:1044-50.
http://dx.doi.org/10.2337/diacare.13.10.1044
 
18. Schwedes U, Siebolds M, Mertes G; SMBG Study Group. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care 2002; 25:1928-32.
http://dx.doi.org/10.2337/diacare.25.11.1928
 
19. Guerci B, Drouin P, Grangé V, et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab 2003; 29:587-94.
http://dx.doi.org/10.1016/S1262-3636(07)70073-3
 
20. Allemann S, Houriet C, Diem P, Stettler C. Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: a systematic review and meta-analysis. Curr Med Res Opin 2009; 25:2903-13.
http://dx.doi.org/10.1185/03007990903364665
 
21. McAndrew L, Schneider SH, Burns E, Leventhal E. Does patient blood glucose monitoring improve diabetes control? A systematic review of the literature. Diabetes Educ 2007; 33:991-1010.
http://dx.doi.org/10.1177/0145721707309807
 
22. McIntosh B, Yu C, Lal A, et al. Efficacy of self-monitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin: a systematic review and meta-analysis. Open Med 2010;4:e102-13.
 
23. Mastura I, Mimi O, Piterman L, Teng CL, Wijesinha S. Self-monitoring of blood glucose among diabetes patients attending urban government health clinics. Med J Malaysia 2007; 62:147-51.
 
24. Tan MY, Magarey J. Self-care practices of Malaysian adults with diabetes and sub-optimal glycaemic control. Patient Educ Couns 2008; 72:252-67.
http://dx.doi.org/10.1016/j.pec.2008.03.017
 
25. Adams AS, Mah C, Soumerai SB, et al. Barriers to self-monitoring of blood glucose among adults with diabetes in an HMO: a cross sectional study. BMC Health Serv Res 2003; 3:6.
http://dx.doi.org/10.1186/1472-6963-3-6
 
26. Clarke PM, Gray AM, Briggs A, et al. A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). Diabetologia 2004; 47:1747-59.
http://dx.doi.org/10.1007/s00125-004-1527-z
 
27. Cameron C, Coyle D, Ur E, Klarenbach S. Cost-effectiveness of selfmonitoring of blood glucose in patients with type 2 diabetes mellitus managed without insulin. CMAJ 2010; 182:28-34.
http://dx.doi.org/10.1503/cmaj.090765
 
28. Farmer AJ, Wade AN, French DP, et al. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial. Health Technol Assess 2009; 13:iii-iv, ix-xi, 1-50.
 
29. Gallichan M. Self monitoring of glucose by people with diabetes: evidence based practice. BMJ 1997; 314:964-7.
http://dx.doi.org/10.1136/bmj.314.7085.964
 
30. Simon J, Gray A, Clarke P, et al. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. BMJ 2008; 336:1177-80.
http://dx.doi.org/10.1136/bmj.39526.674873.BE
 
31. O'Kane MJ, Bunting B, Copeland M, Coates VE; ESMON study group. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. BMJ 2008; 336:1174-7.
http://dx.doi.org/10.1136/bmj.39534.571644.BE
 
32. American Diabetes Association. Standard of Medical Care in Diabetes – 2010. Diabetes Care 2010; 33 suppl 1:S11-S61.
http://dx.doi.org/10.2337/dc10-S011
 
33. Zgibor JC, Simmons D. Barriers to blood glucose monitoring in a multiethnic community. Diabetes Care 2002; 25:1772-7.
http://dx.doi.org/10.2337/diacare.25.10.1772